Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Harvard Business School
Baxter

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Cardene In 0.83% Sodium Chloride In Plastic Container patents expire, and when can generic versions of Cardene In 0.83% Sodium Chloride In Plastic Container launch?

Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi Usa Inc and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-three patent family members in eleven countries.

The generic ingredient in CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

Drug patent expirations by year for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
Recent Clinical Trials for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
Vanderbilt University Medical CenterPhase 2
University of ZurichPhase 4

See all CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER clinical trials

Recent Litigation for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Identify potential future generic entrants

District Court Litigation
Case NameDate
Cornerstone Biopharma Inc. v. Exela Pharma Sciences LLC2013-07-24
CHIESI USA, INC. v. SANDOZ INC.

See all CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER litigation

PTAB Litigation
PetitionerDate
Sandoz Inc.2014-10-01

See all CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER litigation

Paragraph IV (Patent) Challenges for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

US Patents and Regulatory Information for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Express Scripts
Moodys
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.